B. Riley Wealth Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-146,795
Closed -$2.92M 1413
2024
Q1
$2.92M Buy
+146,795
New +$2.66M 0.08% 244
2023
Q4
Sell
-146,795
Closed -$2.92M 1409
2023
Q3
$2.92M Buy
146,795
+89,246
+155% +$1.69M 0.08% 244
2023
Q2
$1.08M Sell
57,549
-17,611
-23% -$355K 0.02% 543
2023
Q1
$1.53M Buy
+75,160
New +$1.51M 0.04% 426
2022
Q4
Sell
-124,771
Closed -$2.54M 1505
2022
Q3
$2.54M Buy
124,771
+9,118
+8% +$182K 0.08% 257
2022
Q2
$2.52M Buy
115,653
+45,737
+65% +$923K 0.11% 195
2022
Q1
$1.28M Buy
+69,916
New +$1.29M 0.04% 405

Other funds holding BTAL

B. Riley Wealth Advisors's BTAL Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2024, closing a stake of 146,795 shares — an estimated $2.92M sold.

B. Riley Wealth Advisors first reported a position in BTAL in Q1 2022 and held it in 7 quarters. The position peaked at $2.92M in Q1 2024. 59 funds tracked by Wall St. Rank hold BTAL as of Q2 2024.

  • B. Riley Wealth Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 146,795 AGF US Market Neutral Anti-Beta Fund shares in Q2 2024, an estimated $2.92M.
  • B. Riley Wealth Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2022 and held it in 7 quarters.
  • B. Riley Wealth Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $2.92M in Q1 2024.
  • 59 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.